Seeberg A H, Tolxdorff-Neutzling R M, Wiedemann B
Antimicrob Agents Chemother. 1983 Jun;23(6):918-25. doi: 10.1128/AAC.23.6.918.
About 70% of all Enterobacter cloacae strains tested possessed one of two species-specific beta-lactamases. These enzymes, E. cloacae beta-lactamase A and E. cloacae beta-lactamase B, with isoelectric points of 8.8 and 7.8, respectively, had the same pH and temperature optima. Both showed similar enzyme kinetics and were inhibited by cloxacillin but not by p-chloromercuribenzoate. E. cloacae beta-lactamase B appeared to be identical with the enzyme of E. cloacae P99. By a mutation in a regulatory gene, inducible enzyme production could be converted into constitutive expression. In E. cloacae, both enzymes did not hydrolyze third-generation cephalosporins, but they were solely responsible for resistance toward these drugs. This was demonstrated by the characterization of Escherichia coli strains expressing an identical resistance pattern after transfer of the corresponding Enterobacter gene.
在所有测试的阴沟肠杆菌菌株中,约70% 拥有两种种特异性β-内酰胺酶之一。这些酶,即阴沟肠杆菌β-内酰胺酶A和阴沟肠杆菌β-内酰胺酶B,其等电点分别为8.8和7.8,具有相同的最适pH值和温度。两者表现出相似的酶动力学,并且被氯唑西林抑制,但不被对氯汞苯甲酸抑制。阴沟肠杆菌β-内酰胺酶B似乎与阴沟肠杆菌P99的酶相同。通过调节基因中的突变,可诱导的酶产生可转化为组成型表达。在阴沟肠杆菌中,这两种酶都不水解第三代头孢菌素,但它们是对这些药物耐药的唯一原因。在转移相应的肠杆菌基因后,表达相同耐药模式的大肠杆菌菌株的特性证明了这一点。